Aquestive Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 07 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3,036.6% | -68.3% | -32.2% | +143.6% | -55.1% | +92.0% | -40.5% | -4.7% | +26.8% | -24.9% | -12.0% | +11.6% | +32.2% | -46.6% | +147.3% | -61.9% | -13.5% | +55.6% | +38.0% | -13.4% | -16.6% | +10.8% | +8.1% | -13.6% | -6.8% | +4.2% | +18.9% | -1.8% | +1.6% | -8.7% | +66.8% | -32.6% | -12.4% | -26.5% | +14.7% | +28.0% | +1.6% | +11.0% | -4.3% | – | |
| – | +1,356.5% | -66.2% | +22.9% | -5.1% | +15.1% | +0.4% | -11.8% | +12.4% | -14.4% | -26.8% | +54.6% | -14.3% | +46.3% | -46.1% | -3.3% | -15.9% | -6.4% | -1.1% | +62.0% | -1.5% | -23.5% | +25.2% | +24.4% | -11.8% | +14.7% | -10.7% | +39.7% | -27.5% | -2.5% | -6.2% | +3.1% | -2.0% | +1.9% | -19.2% | +24.9% | -1.2% | +29.5% | -40.6% | +15.8% | – | |
| – | +4,320.3% | -65.4% | -51.0% | +271.0% | -70.4% | +170.1% | -49.6% | -14.3% | +56.8% | -24.1% | -37.5% | +36.2% | +23.8% | -47.0% | +255.2% | -70.9% | -17.4% | +91.8% | +30.1% | -18.3% | -13.2% | +4.5% | -0.4% | -14.8% | -21.4% | +19.0% | +3.5% | +23.9% | +3.9% | -10.1% | +103.2% | -41.5% | -19.3% | -31.0% | +7.4% | +52.5% | -13.5% | +52.9% | -10.7% | – | |
| – | +2,172.1% | -65.4% | -9.5% | +17.5% | +10.3% | -21.8% | +63.1% | -43.3% | +25.3% | -24.3% | +89.4% | -37.9% | -39.6% | +42.4% | -11.6% | +88.7% | -39.0% | -17.3% | +16.5% | +10.9% | -6.9% | +8.5% | +8.9% | -37.8% | +32.4% | -17.1% | -2.1% | -8.0% | -9.6% | +105.4% | -29.8% | +26.6% | -6.7% | +9.0% | -23.4% | +10.4% | -29.4% | +31.5% | -5.8% | – | |
| – | +781.7% | -83.1% | -14.8% | +18.0% | +22.8% | +0.1% | +344.5% | -63.3% | +51.5% | -4.3% | -9.3% | -15.6% | +20.1% | -11.3% | -4.9% | -15.0% | +23.8% | +6.6% | -15.7% | -7.7% | +23.5% | -13.1% | +19.7% | -20.1% | -5.2% | -36.9% | -1.3% | +0.3% | +29.3% | +11.9% | +6.2% | +6.8% | +32.0% | +19.1% | -33.4% | +20.0% | +115.2% | -66.6% | +8.3% | – | |
| – | +832.9% | -78.2% | -12.3% | +17.7% | +16.8% | -9.9% | +233.9% | -59.5% | +44.5% | -8.9% | +9.8% | -23.0% | +4.0% | -2.9% | -6.5% | +7.5% | +5.0% | -15.6% | +3.0% | -3.1% | +15.0% | -8.2% | +16.8% | -24.5% | +2.5% | -31.6% | -1.5% | -2.3% | +17.6% | +33.6% | -6.6% | +12.1% | +20.3% | +16.8% | -31.2% | +17.7% | +82.1% | -57.9% | +18.7% | – | |
| – | – | – | -619.7% | – | -169.6% | – | -716.1% | – | – | – | – | – | – | – | – | -3,588.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -15,172.7% | – | – | – | – | – | – | – | – | |
| – | +237.9% | -70.4% | +7.2% | +1.1% | +0.0% | -2.2% | +0.0% | +0.3% | -1.6% | +1.3% | +0.6% | +36.9% | +5.7% | -1.1% | -0.9% | +1.1% | +70.1% | +30.1% | +1.2% | +5.8% | -45.5% | -3.0% | +2.6% | +3.2% | -53.8% | -12.7% | -4.0% | -8.1% | +146.6% | +29.8% | -0.1% | +0.1% | +0.6% | +1.3% | 0.0% | -0.1% | +0.0% | -7.9% | -2.4% | – | |
| – | – | – | – | – | -218.8% | – | -990.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -168.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +7.2% | -100.0% | – | -1.0% | -42.1% | +71.1% | -41.3% | -141.9% | – | +1,633.3% | -124.6% | – | -82.4% | -55.6% | -13,875.0% | – | – | -100.3% | – | -81.7% | +1.7% | -99.9% | +115,840.0% | -293.9% | – | -149.3% | – | +62.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -218.8% | – | -990.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -171.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -275.5% | – | -162.3% | – | -584.2% | – | – | – | – | – | – | – | – | -1,184.3% | – | – | – | – | – | – | – | – | – | – | -138.4% | – | – | – | – | -532.1% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.